21st Mar 2006 07:04
Advanced Medical Solutions Grp PLC21 March 2006 For immediate release 21 March 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") Manufacturing facilities receive latest ISO approval Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalwoundcare technology company, today announces that its two UK manufacturingfacilities have both been registered to ISO 13485: 2003 following audits bytheir respective notified bodies. ISO 13485 is the international standard covering quality systems for medicaldevice manufacturers. The latest version of this standard was introduced in2003. Audits are carried out by the manufacturer's notified body whichrecommends approval and subsequently conducts regular surveillance audits toensure ongoing compliance. Approval of its quality system is a key part ofRegulatory compliance that allows the Company to CE Mark its products for salein Europe under the Medical Device Directive and provides the basis for approvalinto all other international markets. AMS was previously registered under ISO13485: 1996. This move to ISO 13485: 2003 demonstrates AMS' continued commitmentto maintaining the highest quality standards. AMS' Plymouth facility was approved in December 2005 following an audit by itsnotified body, TUV Product Service. This facility produces the Company's rangeof medical adhesives for wound closure and skin protection. These are solddirectly into the NHS in the UK under the LiquiBandTM brand and via partners inother markets. AMS' Winsford facility has also now been approved to ISO 13485: 2003, followingan audit by BSI, its notified body. This facility produces a full range ofadvanced woundcare dressings sold either through branded partners, private labelor direct into the NHS under the ActivHealR brand. All AMS products sold worldwide come under the quality systems of one of thesetwo manufacturing facilities and hence now comply with the latest internationalquality system. Commenting on this announcement Dr. Don Evans, Chief Executive of AMS, stated: "These approvals further endorse AMS as a world class manufacturer. Ourcustomers can be confident that the products they purchase from the Company meetthe highest levels of quality assurance for medical devices. I am delighted thatAMS now complies with the latest international quality system". For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS' resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS' technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group